{
    "clinical_study": {
        "@rank": "156447", 
        "acronym": "Early CF", 
        "biospec_descr": {
            "textblock": "Blood Urea, Bronchopulmonary Lavage samples, Nasal swabs and Oral swabs"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to test the hypothesis that early viral infections alter the\n      bacterial flora and inflammatory profile in the airway and accelerate progression of\n      pulmonary disease in infants with cystic fibrosis."
        }, 
        "brief_title": "Viral Pathogenesis of Early Cystic Fibrosis Lung Disease", 
        "completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Cystic Fibrosis", 
        "condition_browse": {
            "mesh_term": [
                "Cystic Fibrosis", 
                "Fibrosis", 
                "Lung Diseases", 
                "Pulmonary Fibrosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "The proposed study is a unique international collaboration between three large CF research\n      centers. This proposal will determine the impact of early respiratory viral infections on\n      bacterial flora and inflammatory profiles in the CF airway as well as the impact of these\n      pathogens on clinical, physiologic and structural markers of disease.The proposed study is\n      designed to follow infants diagnosed with CF through newborn screening to determine the\n      effect of viral infections on the lower airway microbiome, clinical symptoms, pulmonary\n      function and structural changes during the first year of life. The proposed study will\n      measure lower airway inflammation and infection using BAL, oral swabs, and nasal swabs;\n      outcomes will be assessed through infant lung function testing, computerized tomography\n      scans of the chest, and pulmonary exacerbation rate."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Diagnosis of CF by newborn screening, at least one clinical feature of CF, and\n             documented sweat chloride greater than 60 mEq/L by quantitative pilocarpine\n             iontophoresis or compatible genotype with two identifiable mutant CFTR alleles.\n\n          2. Less than 4 months of age at Screening Visit\n\n          3. Ability to comply with study visits and study procedures as judged by site\n             investigator.\n\n        Exclusion Criteria:\n\n          1. Intercurrent respiratory illness, defined as increase in cough, wheezing, or\n             respiratory rate with onset 14 days before iPFT-bronchoscopy visit.\n\n          2. Measured hemoglobin oxygen saturation less than 95% during the iPFT-bronchoscopy\n             visit.\n\n          3. History of adverse reaction to sedation.\n\n          4. Clinically significant upper airway obstruction as determined by the site\n             investigator.\n\n          5. Severe gastroesophageal reflux, defined as persistent frequent emesis despite\n             therapy.\n\n          6. Major organ dysfunction, not including pancreatic dysfunction.\n\n          7. Physical findings that would compromise the safety of the subject or the quality of\n             the study data as determined by site investigator."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "4 Months", 
            "minimum_age": "2 Months", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Infants, less than 4 months of age who have been diagnosed with Cystic Fibrosis"
            }
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01973192", 
            "org_study_id": "1R01HL116211-01", 
            "secondary_id": "1R01HL116211-01"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "October 25, 2013", 
        "location": [
            {
                "contact": {
                    "email": "mheskett@iu.edu", 
                    "last_name": "Mary Heskett, RN, BSN, CCRP"
                }, 
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46202"
                    }, 
                    "name": "Riley Hospital for Children at Indiana University Health"
                }, 
                "investigator": {
                    "last_name": "Stephanie D Davis, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "quante_j@kids.wustl.edu", 
                    "last_name": "Jane Quante", 
                    "phone": "314-454-2353"
                }, 
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri"
                    }, 
                    "name": "St. Louis Children's Hospital"
                }, 
                "investigator": {
                    "last_name": "Thomas Ferkol, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "billy.skoric@mcri.edu.au", 
                    "last_name": "Billy Skoric", 
                    "phone": "+011-61-3-9345-5843"
                }, 
                "facility": {
                    "address": {
                        "city": "Melbourne", 
                        "country": "Australia", 
                        "state": "Victoria"
                    }, 
                    "name": "The Royal Children's Hospital"
                }, 
                "investigator": {
                    "last_name": "Sarath Ranganathan, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Australia"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "Viral Pathogenesis of Early Cystic Fibrosis Lung Disease", 
        "other_outcome": {
            "description": "To evaluate the association of early viruses on the development of early lung disease in CF infants as defined through comprehensive structural and airway modeling techniques.", 
            "measure": "Bronchiectasis", 
            "safety_issue": "No", 
            "time_frame": "12 Months"
        }, 
        "overall_contact": {
            "email": "mheskett@iu.edu", 
            "last_name": "Mary Heskett, RN, CCRP"
        }, 
        "overall_official": {
            "affiliation": "Indiana University School of Medicine", 
            "last_name": "Stephanie D. Davis, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To determine the effect(s) of viral infections on the evolution of endobronchial bacterial infection and inflammation in CF infants.", 
            "measure": "Viral infection", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01973192"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "To identify the impact of respiratory viruses on the onset, frequency, and duration of respiratory symptoms in CF infants diagnosed through newborn screening.", 
                "measure": "Pulmonary exacerbation rate", 
                "safety_issue": "No", 
                "time_frame": "12 Months"
            }, 
            {
                "description": "To assess development of early lung disease as defined through physiological measures of forced expiratory flows, lung volumes, and ventilation inhomogeneity in CF infants.", 
                "measure": "Forced Expiratory Volume", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }
        ], 
        "source": "Indiana University", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "National Institutes of Health (NIH)", 
                    "agency_class": "NIH"
                }, 
                {
                    "agency": "National Heart, Lung, and Blood Institute (NHLBI)", 
                    "agency_class": "NIH"
                }
            ], 
            "lead_sponsor": {
                "agency": "Indiana University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2013"
    }
}